ArticleCureus2025
Postoperative Pain Management in Patients with Lower-Extremity Amputations: A Single-Institution Retrospective Analysis of the Effectiveness of Non-opioid Analgesics in Reduction of Opioid Use.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPain management following lower extremity amputation remains a clinical challenge, particularly during inpatient rehabilitation. Although opioids are frequently used, their adverse effects and potential for prolonged use highlight the importance of multimodal pain strategies. This study investigated the relationship between specific non-opioid analgesics and reductions in opioid use among patients undergoing inpatient rehabilitation after major lower extremity amputation.
methodsA retrospective review was conducted at a single inpatient rehabilitation facility (IRF), examining opioid utilization measured in morphine milligram equivalents (MME) and the concurrent use of non-opioid agents, including acetaminophen, methocarbamol, gabapentin, pregabalin, and duloxetine. Eighty-one patients admitted between January 2021 and December 2023 were included. Admission and discharge opioid requirements were compared with daily non-opioid doses. Statistical analyses were performed using STATA version 3 (StataCorp LLC, College Station, TX).
resultsGabapentin use was associated with a significant decrease in MME from admission to discharge (p=0.04), with an average daily dose of 1000 mg corresponding to a reduction of 1 MME per day. In multivariable analysis incorporating all non-opioid medications, gabapentin and pregabalin both showed significant associations with reduced MME (p=0.021 and p=0.027, respectively).
conclusionAmong patients recovering from lower extremity amputation during inpatient rehabilitation, gabapentin use was significantly associated with lower opioid requirements, with pregabalin demonstrating a similar pattern. Incorporating these agents into multimodal analgesic regimens may help optimize postoperative pain control and limit opioid exposure. Further research is warranted to explore the role of additional non-opioid options in this setting.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.